Sun Z - Search Results

1

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX. Liang Y, et al. Among authors: sun z. Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y. Nat Commun. 2018. PMID: 30389912 Free PMC article.

2

Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination.

Zhu D, Liu L, Yang D, Fu S, Bian Y, Sun Z, He J, Su L, Zhang L, Peng H, Fu YX. Zhu D, et al. Among authors: sun z. J Immunol. 2016 Apr 1;196(7):3079-87. doi: 10.4049/jimmunol.1502061. Epub 2016 Mar 2. J Immunol. 2016. PMID: 26936879 Free PMC article.

3

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Among authors: sun z. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

4

Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.

Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, Fu S, Guo J, Liu L, Su L, Wang FS, Fu YX, Peng H. Bian Y, et al. Among authors: sun z. Hepatology. 2017 Oct;66(4):1067-1082. doi: 10.1002/hep.29239. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28445927 Free PMC article. Clinical Trial.

5

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression.

Liao J, Luan Y, Ren Z, Liu X, Xue D, Xu H, Sun Z, Yang K, Peng H, Fu YX. Liao J, et al. Among authors: sun z. Cancer Immunol Res. 2017 Jul;5(7):560-570. doi: 10.1158/2326-6066.CIR-16-0221. Epub 2017 May 22. Cancer Immunol Res. 2017. PMID: 28533311 Free PMC article.

6

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response.

Yang K, Liang Y, Sun Z, Xue D, Xu H, Zhu M, Fu YX, Peng H. Yang K, et al. Among authors: sun z. J Virol. 2018 Jun 29;92(14):e00428-18. doi: 10.1128/JVI.00428-18. Print 2018 Jul 15. J Virol. 2018. PMID: 29743364 Free PMC article.

7

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection.

Yang K, Liang Y, Sun Z, Liu L, Liao J, Xu H, Zhu M, Fu YX, Peng H. Yang K, et al. Among authors: sun z. Sci Rep. 2018 Dec 7;8(1):17727. doi: 10.1038/s41598-018-36012-z. Sci Rep. 2018. PMID: 30531962 Free PMC article.

8

Targeting tumor cells with antibodies enhances anti-tumor immunity.

Sun Z, Fu YX, Peng H. Sun Z, et al. Biophys Rep. 2018;4(5):243-253. doi: 10.1007/s41048-018-0070-2. Epub 2018 Oct 29. Biophys Rep. 2018. PMID: 30533489 Free PMC article.

9

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Nat Commun. 2019 Aug 28;10(1):3874. doi: 10.1038/s41467-019-11782-w. Nat Commun. 2019. PMID: 31462678 Free PMC article.

10

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Nat Commun. 2020 Apr 1;11(1):1716. doi: 10.1038/s41467-020-15532-1. Nat Commun. 2020. PMID: 32238807 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,645 results

Search Page

Filters